Source:http://linkedlifedata.com/resource/pubmed/id/14971381
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2004-2-18
|
pubmed:keyword | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
E
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0099-9660
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:owner |
KIE
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
A1, A11
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14971381-Clinical Trials as Topic,
pubmed-meshheading:14971381-Continuity of Patient Care,
pubmed-meshheading:14971381-Drug Industry,
pubmed-meshheading:14971381-Drugs, Investigational,
pubmed-meshheading:14971381-Humans,
pubmed-meshheading:14971381-Refusal to Treat,
pubmed-meshheading:14971381-Research Design,
pubmed-meshheading:14971381-Research Subjects,
pubmed-meshheading:14971381-United States
|
pubmed:year |
2003
|
pubmed:articleTitle |
How some patients in new-drug trials can get cut off.
|
pubmed:publicationType |
Newspaper Article
|